123ArticleOnline Logo
Welcome to 123ArticleOnline.com!

ALL >> Business >> View Article

Harver Group Investing Heavily In Potential Cancer Cure

By Author: Harver Group
Total Articles: 26

Jul. 22, 2013 - CHUO-KU, Japan -- Harvard Bioscience Inc. (HBIO) has received little attention for their research from the medical establishment or from educational institutions. While posting consistent growth and a strong customer base, shareholders have not seen much profit to date due to operating losses from the company´s Regenerative Medical Device division also known as Harvard Apparatus Regenerative Technology.

“We believe that Harvard Bioscience Inc. is a solid investment now” said Peter Anderson Senior Vice President of Mergers and Acquisitions at Harver Group, “before Harvard Apparatus Regenerative Technology is given an initial public offering”.

Head of Investment Analysis, Mr. Nathan Marx said “Removing Harvard Apparatus from their balance sheets should lead to an increase in valuation of at least 50% in the short term and potentially 100% in the long term if shareholder friendly policies are enacted. We expect the IPO to happen within four months”.

Harvard Apparatus Regenerative Technology is pursing ground breaking research; they are preforming clinical trials of their cure for trachea cancer. The trials have produced very exciting results, with a high survival rate for a typically fatal form of cancer. They’ve created scaffolding, which in conjunction with cells from the patient construct a new trachea. This technology has further applications, for lung and heart, heart valve, liver, and kidney transplants as well as esophageal cancer.

Both the President and CFO of Harvard Bioscience Inc. will be leaving to run Harvard Apparatus Regenerative Technology. We believe that this indicates that a sale of Harvard Bioscience is in the works, due to the fact that the President and CFO along with other members of management own 14% of the company. Management will likely maximize value, and sell the company for at least $10 a share. We are recommending our clients to move on Harvard Bioscience Inc. as soon as possible and we will bring more news on Harvard Apparatus Research Technology IPO as we receive it.

Total Views: 80Word Count: 321See All articles From Author

Business Articles

1. Why Video Transfers Have Become So Essential At Present?
Author: alphadvdcreations

2. Video Transfer Method To Keepyourfavourites For Life
Author: alphadvdcreations

3. How Compact Lube Trucks Can Increase Industrial Maintenance Capabilities
Author: Scott Lee

4. 5 Tips To Get Your Construction Business Visible In Canada
Author: Rick Greoneveld

5. Why Retailers Need Ecommerce Product Catalog Management?
Author: Liza Zeimer

6. Cutlery For Wedding Should Have A Smooth Reflection And Smooth Edges!
Author: Dean Lance

7. Htc Screen Repair And Replacement In Uk
Author: Rosie Grace

8. Cutlery For Wedding Made From Copper Is Always Safe On The Use!
Author: Dean Lance

9. Floor Lamps South Africa Is Safe And Extremely Beneficial On The Use!
Author: Dean Lance

10. Stem Floor Lamp Is Designed To Produce Perfect Accent Of Lighting For Your Home!
Author: Dean Lance

11. To Be Appropriate For Benefiting Instant Cash For Me
Author: Jack martin

12. Opportunities For The Global Waterproofing Admixture Market To Reach $4.5 Billion By 2023
Author: Lucintel

13. Money Loan Specialist Carries On In A Positive Sense And Answers
Author: Alex Mighty

14. How To Increase Sales By Using Just One Word
Author: Ian Marsh

15. Xbox Game Console Repair Services In Uk
Author: Rosie Grace

Login To Account
Login Email:
Password:
Forgot Password?
New User?
Sign Up Newsletter
Email Address: